Click here to view the full program

Friday, January 15

0730

Registration Desk Opens / Continental Breakfast

0800 – 0810

Welcome – Dr. Penny Barnes,  Queen Elizabeth II Health Science Centre and Dalhousie University, Halifax, NS 

0810 – 0830

 “The RCPSC GP Exam – Format, General Information and How to Perform at Your Best”
Dr. Russell Price, Royal Victoria Hospital, Barrie, ON

At the end of this session, participants will:

  • Have a clear understanding of the overall format of the RCPSC exam in General Pathology.
  • Have additional knowledge of the evaluation processes that guide the GP examination.
  • Be aware of techniques to maximize success in all components of the exam.

0830 – 0930

“Medical Biochemistry Review”
Dr. Russel Price, Royal Victoria Hospital, Barrie, ON
(45 minute presentation, 15 minutes Q&A)

At the end of this session, participants will:

  • Understand the management of the clinical laboratory
  • Understand quality control in the clinical biochemistry laboratory
  • Reporting of critical results – how is this managed?
  • Understand the principles of managing a “Point of Care” testing program

0930 - 1030

“Diabetes Testing, Biochemical Markers of Cardiac Injury, Clinical Toxicology & Chemistry Laboratory Safety”
Dr. Zaiping Liu, IWK Health Center and Dalhousie University, Halifax, NS
(45 minute presentation, 15 minutes Q&A)

At the end of this session, participants will have a better understanding of:

  • Explain the principles of biochemical testing in the diagnosis and management of diabetes.
  • Discuss the methods of testing biochemical markers in cardiovascular disease and cardiac injury.
  • State the basic principles of clinical toxicology testing including toxicology screening in the community hospital.

1030 – 1045

Refreshment Break

1045 - 1145

“Medical Biochemistry Review”
 Presenter Dr. Davinder Sidhu, Calgary Laboratory Services, Calgary, AB
 (45 minute presentation, 15 minute Q&A)

At the end of this session, participants will:

  • Describe the common types of laboratory errors.
  • Understand the major challenges posed by increasing/inappropriate laboratory utilization. 
  • List the steps in laboratory analyzer validation.

1145 – 1245

Lunch

1245 – 1250

Opening Remarks – Dr. Jagdish Butany, University Health Network, Toronto,

1250 – 1330

“The RCPSC AP Exam – Format, General Information and How to Perform at Your Best”
Presenter – Dr. David Driman, London Health Sciences Centre, University of Western Ontario, London, ON
 (30 minute presentation, 10 minute Q&A)

At the end of this session, participants will be able to:

  • Have a clear understanding of the overall format of the RCPSC exam in Anatomical Pathology.
  • Have additional knowledge of the evaluation processes that guide the AP examination.
  • Be aware of techniques to maximize success in all components of the exam.

1330-1400

“Pancreatic Pathology Selected Topics”
Presenter – Dr. David Driman, London Health Sciences Centre, University of Western Ontario, London ON
(20 minute presentation, 10 minute Q&A)

At the end of this session, participants will be able to:

  • List the tumors unique to the pancreas and gross, microscopic differences.
  • Discuss the use of immunohistochemistry in diagnosing pancreatic neoplasms.
  • List the diagnostic criteria for IgG4-related pancreatitis.

1400-1445

“Quality Assurance in Surgical Pathology’’
Dr. Dipokar Banerjee, Eastern Ontario Regional Laborator Association (EORLA), Ottawa, ON
(30 minute presentation, 15 minute Q&A)

 

1445-1500

Refreshment Break

1500-1600

“Gastrointestinal Pathology:  Snapshot Review of Relevant Topics for an Emerging Pathologist’’
Dr. David Schaeffer, Vancouver General Hospital, Vancouver, BC
(45 minute presentation, 15 minute Q&A)

At the end of this session, participants will be able to:

  • List different types of esophagitis, gastritis, duodenitis and colitis and discuss how to distinguish among entities within these differential diagnoses.
  • Discuss how to report dysplasia within Barrett esophagus and inflammatory bowel disease and explain the management implications; discuss the approach to testing for hereditary gastric and colorectal cancer.
  • Explain how to diagnose gastrointestinal stromal tumours and neuroendrocrine tumours and discuss their reporting criteria.

1600 – 1645

“Practical Overview of Prostate, Kidney, Bladder and Testicular Tumour Pathology”
Dr. Andrew Evans, University Health Network, Toronto, ON
(45 minute presentation, 15 minute Q&A)

At the end of this session, participants will be able to:

  • List the most commonly encountered tumour types in prostate, kidney, bladder and testis specimens.
  • Discuss the appropriate use of immunohistochemical stains that can be used to aid in the diagnosis of these tumours.
  • List the appropriate staging information that must be included in cancer resection specimens from prostate, kidney, bladder and testis.

1645 – 1745

“Forensic Pathology for the Senior Resident”
Dr. Matt Bowes, Nova Scotia Medical Examiner Service, Halifax, NS
(45 minute presentation, 15 minute Q&A)

At the end of this session, participants will be able to:

  • Explain the difference between cause, manner and mechanisms of death.
  • Discuss the features of some common recognizable patterns of human injury, including blunt and sharp force injuries, gunshot wounds, and findings referable to drug abuse.
  • Explain the importance of the death scene, with specific reference to cases where the scene findings are important to the cause of death determination.

1745 - ?

Anatomic Pathology Attendees Adjourned for the day (on your own for dinner)

1745 – 1830

Dinner and Break – Dinner on Own (No Meal Provided)


1830-2015

“Medical Microbiology”
Dr. Phillippe Lagacé-Wiens, St. Boniface General Hospital, Winnipeg, MB
(1 hr 15 minute presentation, 30 minutes Q&A)

At the end of this session, participants will have a better understanding of the:

  • Management of the clinical microbiology laboratory – preanalytical, analytical and post-analytical considerations.
  • QC, QC and QM in the microbiology laboratory.
  • Major pathogens in bacteriology – relevance, identification and susceptibility testing.

Selected key points in mycology, mycobacteriology, parasitology, virology and serology testing.

2015-2100

“Infection Control Pearls for the Pathologist”
Dr. Susan Poutanen, Mt. Sinai Hospital, Toronto, ON
(30 minute presentation, 15 minutes Q&A)

  • Describe the components of an effective Infection Control Program.
  • Discuss the supportive role that infection control programs play with:
  • Occupational Health
  • Antimicrobial Stewardship, and
  • Laboratory Biosafety
  • Summarize the laboratory’s role in supporting infection control programs.

 

Saturday, January 16

0730 – 0800

Continental Breakfast

0800 – 0830

“Diagnostic Immunohistochemistry”
Dr. Martin Trotter, Providence Health Care, Vancouver, BC
(20 minute presentation, 10 minute Q&A)

At the end of this session, participants will be able to:

  • Explain the importance of the pre-analytic phase in quality and validity of immunohistochemistry stains.
  • Describe the technical components of an immunohistochemistry test and list the types of controls which should be used.
  • List the important components of new test validation for both class I and class II immunostains.

0830 – 0900

“Skin Pathology”
Dr. Shachar Sade, Sunnybrook Health Science Centre, Toronto, ON
(20 minute presentation, 10 minute Q&A)  

At the end of this session, participants will be able to:

  • Diagnose 10 of the most common neoplastic skin conditions.
  • Know common inflammatory patterns of the skin and be able to diagnose the archetypes for each pattern.
  • Have an approach to melanocytic lesions and be able to perform a synoptic report for melanoma.

0900-1000

“Important Entities in Head and Neck Pathology”
Dr. Susan Battistuzzi, University of Manitoba, Winnipeg, MB   
(45 minute presentation, 15 minute Q&A)

At the end of this session, participants will be able to:

  • Discuss common thyroid pathology.
  • Discuss important salivary gland tumours.
  • Discuss important lesions of the sinonasal tract/nasopharynx as well as squamous lesions of the head and neck.

1000-1015

Refreshment Break

1015-1045

“Cardiovascular Surgical and Autopsy Pathology – An Overview”
Dr. Vidhya Nair, McMaster University and Hamilton Health Sciences, Hamilton, ON
(20 minute presentation, 10 minute Q&A)

At the end of this session, participants will be able to:

  • Develop an approach to the diagnosis of commonly encountered native valve pathology.
  • List and discuss common cardiovascular findings in sudden death patients.
  • Recognize commonly encountered cardiac neoplasm.

1045-1145

“Breast Pathology”
Dr. Penny Barnes, Queen Elizabeth II Health Science Centre and Dalhousie University, Halifax, NS
(45 minute presentation, 10 minute Q&A)

At the end of this session, participants will be able to:

  • Discuss common in situ proliferative breast lesions and their risk implications.
  • Discuss prognostic and predictive factors for breast carcinoma, including biomarkers and treatment effects.
  • Review the spectrum of fibroepithelial and stromal breast lesions.

1145-1245

Lunch
Luncheon Seminar from 1200-1230
Dr. Brian Cummings, Grand River Hospital, Kitchener-Waterloo, ON

A brief introduction to the costs, benefits, opportunities and pitfalls of incorporation for the practicing pathologist in Canada as well as a brief overview of current remuneration and working conditions and select advice on negotiations and tax planning for those completing a residency or Fellowship.

At the end of this session, participants will be able to :

  • Provide a brief overview of renumeration and working conditions for Pathologists in Canada
  • Discuss the costs, benefits, opportunities and pitfalls of incorporation for Pathologists and assess whether it may be beneficial for their present or planned positions
  • Highlight some negotiation and tax tips as one finishes training and enters a practice.

1245-1315

“Pediatric Pathology”
Dr. Jeff Terry, McMaster University, Hamilton, ON
(20 minute presentation, 10 minute Q&A)

At the end of this session, participants will be able to:

  • List important diagnostic features of common pediatric neoplasms
  • Summarize important basic concepts in pediatric oncogenesis
  • Identify key gross and histological findings in common placental abnormalities.

1315 -1345

“Liver Pathology:  Recognizing and Appropriately Classifying Key Morphologic Features”
Dr. Oydele Adeyi, University Health Network, Toronto, ON
(20 minute presentation, 10 minute Q&A)

At the end of this session, participants will be able to:

  • Understand the importance of clinic-pathologic correlation in assessing medical liver biopsies.
  • Recognize key inflammatory, neoplastic, and infiltrative patterns especially as they relate to disease process/pathogenesis.
  • Appropriately classify hepatocellular neoplasms using routine and ancillary histopathologic tools.

1345-1415

Gross Pathology (How to Recognize and Make the Diagnosis)
Dr. Zaid Kamil, Health Sciences North, Sudbury, ON
(20 minute presentation, 10 minute Q&A)

At the end of this session, participants will be able to:

  • Identify and approach & dealing with gross specimens.
  • Deal with common gross abnormalities.
  • Develop differential diagnosis strategies.

1415-1445

“Neuropathology”
Dr. Julia Keith, Sunnybrook Health Sciences Centre, Toronto, ON
(20 minute presentation, 10 minute Q&A)

At the end of this session, participants will be able to:

  • Outline an Anatomical Approach to Tumors of The Nervous System
  • Employ a Systematic Approach to Classify Various Disease Entities Affecting the Nervous System, Including Neurodegenerative and Neuromuscular Diseases.
  • Summarize Hot Topics in Neuropathology, Including Glioma Biomarkers.

1445-1500

Refreshment Break

1500-1600

“Gynecological Pathology”
Dr. Maire Duggan, University of Calgary, Calgary, AB
(45 minute presentation, 15 minute Q&A)

At the end of this session, participants will be able to:

  • Explain the pathogenesis of common neoplastic diseases of the female genital tract and current controversies.
  • Summarize the key gross and microscopic features of newly described and controversial diseases of the female genital tract.
  • Discuss the integration of ancillary test results into decision making.

 

1600 – 1700

“Application of Molecular Pathology in Solid and Liquid Tumours”
Dr. Christopher Howlett, University of Western Ontario, London, ON
 (45 minute presentation, 15 minute Q&A)

At the end of this session, participants will be able to:

  • List molecular tests relevant to practice in Pathology.
  • Explain the rationale for performing common molecular tests to improve accuracy of diagnosis in solid and liquid tumours.
  • Discuss the role of particular molecular tests in predicting tumour response to therapy.

 

1700 – 1745

Thoracic Pathology Review"
Dr. Marcio Gomes,
The Ottawa Hospital, Ottawa, ON
(30 minute presentation, 15 minute Q&A)

At the end of this session, participants will be able to:

• Differentiate lung carcinomas according to the 2015 WHO classification
• Distinguish the most common types of interstitial lung disease
• Apply an algorithmic approach to suspicious pleural lesions
• Discuss the differential diagnosis of anterior mediastinal tumours

 

1800 – 1930

Reception for all participants: McCallion Ballroom Foyer – Hilton Garden Inn Toronto Airport

 

1900 - 1930

Resident Section Meeting - Chair Launny Lowden
McCallion Ballroom Foyer – Hilton Garden Inn Toronto Airport

Quick overview of what we have done so far this year, providing updates on activities that are ongoing, and discussing ideas we may wish to pursue during the second half of the year.

Agenda

 

1930 – 2230

Dinner for all participants : McCallion Ballroom – Hilton Garden Inn Toronto Airport

 


Sunday, January 17

0700 – 0730

Continental Breakfast - Note early start

0730 – 0800

“Kidney Pathology - Medical”
Dr. Vina Alexopoulou, McMaster University, Hamilton, ON
(20 minute presentation, 10 minute Q&A)

At the end of this session, participants will be able to:

  • Review topics in medical diseases of the kidney, as they relate to the preparation for the Anatomical Pathology specialty examination.

 

0800 - 0900

“Cytology - Review of Basic Principles”
Dr. Linda Kapusta, University of Toronto, Credit Valley Hospital, Mississauga, ON
(45 minute presentation, 15 minute Q&A)

At the end of this session, participants will be able to:

  • Overview of gynecologic cytology.
  • Overview of non-gynecologic cytology including FNA.
  • Discuss Quality Assurance in Cytology.

0900 – 1000

“Review of Bone and Soft Tissue Pathology”
Dr. Kelly Dakin Hache,QEII Health Sciences CentreHalifax, Nova Scotia
(45 minute presentation, 15 minute Q&A)

At the end of this session, participants will be able to:

  • Identify key factors in the clinical history and radiologic findings that aid in the diagnosis of bone and soft tissue lesions.
  • Summarize the main gross, microscopic immunohistochemical and molecular features of common bone and soft tissue lesions.
  • Discuss the approach to handling bone biopsies for metabolic bone disease, and to soft tissue and bone specimens for neoplastic disease.

1000 – 1015

Refreshment Break

1015 – 1115

“Approach to Work-up and Diagnosis of Hematological Disorders”
Dr. Monalisa Sur, McMaster University, Hamilton, ON
(45 minute presentation, 15 minute Q&A)

At the end of this session, participants will be able to:

  • Handle various specimens in the lab with a clinical diagnosis of a lymphoproliferative disorder.
  • Work up common reactive lymphadenopathies.
  • Use a pattern based approach to create a differential diagnosis and distinguish various indolent and aggressive lymphomas.
  • Understand the role (in diagnosis and prognosis) and judicious use of various ancillary tests such as immunohistochemistry, flow cytometry and molecular tests.

1115-1215

“Bone Marrow evaluation and Flow Cytometry”
Dr. Graeme Quest, Toronto General Hospital, Toronto, ON

At the end of this session, participants will have a better understanding of the:

  • Follow the principles of integrated bone marrow diagnostics.
  • Compare normal vs. abnormal patterns of the main antigen combinations used in the flow cytometric diagnosis of bone marrow.
  • Summarize principles of flow cytometry diagnostics of hematological malignancies.

1215-1300

Lunch (45 minutes)
“ Residents Digital Slide Collection”
Dr. Alison Osmond

(15 minute presentation)

"ExpertPath Presentation"

1300-1345

“Practical Approach to Hematological Evaluation of Peripheral Blood”
Dr. Allam Shawwa, Queen Elizabeth II Health Science Centre, Halifax, NS
35 minute presentation, 10 minute Q&A)

At the end of this session, participants will have a better understanding of the:

  • Practical approach to diagnosis of anemia.
  • Practical approach to diagnosis of acute leukemia, myeloproliferative and myelodysplastic disorders. 
  • Practical approach to lymphocytosis with update on small lymphocyte disorders.

1345-1445

“Coagulopathy Investigations”
Dr. Rita Selby, University of Toronto, ON
(20 minute presentation, 10 minute Q&A)

1445 -1500

Coffee Break

1500 – 1600

“Investigations and Management of Transfusion Reactions”)
Dr. Christine Cserti-Gazdewich, University Health Network, Toronto, ON
(45 minute presentation, 15 minute Q&A) 

At the end of this session, participants will have a better understanding of the:

  • Provide clear guidance toward clinical staff on the recognition and immediate management of Transfusion Reactions.
  • Provide clear guidance to the lab staff on the laboratory investigation of the Transfusion Reactions 
  • Understand and be able to discuss the utility of standard lab investigations for Transfusion Reactions and when to recommend/refer for complex or specialized testing.

1600-1605

Closing Comments -

 


- last updated November 2016 -